No difference between patient mortality rates of experienced and new surgeons
the ONA take:
According to a new study published in the Journal of the American Statistical Association, researchers from the University of Pennsylvania in Philadelphia, Pennsylvania, have found that there is no statistical difference between the patient mortality rates of experienced and new surgeons.
For the study, researchers analyzed data for 130,106 patients who were operated on in 498 hospitals over a period of 2 years from the Medicare database.
The researchers identified 6,620 surgical patients for each group. Results showed that the mortality rate for patients operated on by experienced surgeons was 3.59% compared with 3.71% for patients operated on by new surgeons.
"It is reassuring that new surgeons were able to achieve similar mortality rates to experienced surgeons when caring for similar patients. However, mortality is a relatively rare event that may not expose the benefits of experience," said Dr. Rachel R. Kelz, associate professor of surgery at the University of Pennsylvania.
There is no statistical difference between the patient mortality rates of experienced and new surgeons.
Sign Up for Free e-newsletters
- Distress, Neuroticism Predict Long-term Emotional Distress After Cancer Diagnosis
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- Fosfomycin Effective Alternate for Febrile Neutropenia Prophylaxis
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Bacteria in Probiotics Carry Potential Risks for Immunocompromised Patients
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
- Overall Survival Prolonged With HIPEC + Cytoreductive Surgery for Gastric Cancer
- Better Postoperative Outcomes With RAMIE for Esophageal Cancer
- Distinct Patterns of Shiny White Streaks Strong Indicator of Melanoma
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|